Vensana Capital
Venture Capital
Active
Minneapolis, United States
22
52M
18
3.67
7
0.18
1
- Areas of investment
Summary
Vensana Capital appeared to be the VC, which was created in 2018.
We can highlight the next thriving fund investment areas, such as Medical Device, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vesper Medical, Intact Vascular. The fund has exact preference in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Vensana Capital, startups are often financed by Quaker Partners, New Enterprise Associates, H.I.G. BioHealth Partners. The meaningful sponsors for the fund in investment in the same round are Quaker Partners, New Enterprise Associates, H.I.G. BioHealth Partners.
The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019.
Investor highlights
- Industry focus
- Check size
- 10M — 40M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 325000000
- Fund raised date
- 2021-09-27
Analytics
- Total investments
- 22
- Lead investments
- 7
- Exits
- 1
- Rounds per year
- 3.67
- Follow on index
- 0.18
- Investments by industry
- Health Care (19)
- Medical (14)
- Medical Device (11)
- Biotechnology (9)
- Health Diagnostics (6) Show 17 more
- Investments by region
-
- United States (20)
- France (2)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 18M
- Group Appearance index
- 0.91
- Avg. company exit year
- 9
- Avg. multiplicator
- 2.38
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 21 Jun 2021 | Information Technology, Artificial Intelligence, Health Care, Apps, Education, Medical | Early Stage Venture | 43M | United States, New York, New York | |
| iVEAcare | 22 Apr 2024 | Early Stage Venture | 27M | United States, Minnesota, Minneapolis |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.